| scholarly article | Q13442814 |
| P356 | DOI | 10.1039/C6BM00935B |
| P698 | PubMed publication ID | 28181619 |
| P50 | author | Shao-Lu Li | Q61821388 |
| Hua Lu | Q62751648 | ||
| P2093 | author name string | Wei Wei | |
| Jin Yu | |||
| Yali Hu | |||
| Yingqin Hou | |||
| P2860 | cites work | Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT) | Q22011094 |
| Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein trafficking | Q27011482 | ||
| The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs | Q28066801 | ||
| Enzymatically triggered self-assembly of block copolymers | Q33501301 | ||
| Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads | Q33506479 | ||
| Polymer--cisplatin conjugate nanoparticles for acid-responsive drug delivery | Q33695863 | ||
| Co-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulation. | Q33716011 | ||
| Pt(IV) prodrugs designed to bind non-covalently to human serum albumin for drug delivery | Q33825880 | ||
| Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. | Q34447986 | ||
| Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer | Q34479313 | ||
| Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo | Q34550075 | ||
| The resurgence of platinum-based cancer chemotherapy | Q34649255 | ||
| Polysilsesquioxane nanoparticles for triggered release of cisplatin and effective cancer chemoradiotherapy | Q34791190 | ||
| Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy | Q35216251 | ||
| α(V)β(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug | Q35981228 | ||
| Protein-tyrosine phosphatases and cancer | Q36430193 | ||
| A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy | Q36635458 | ||
| Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy. | Q36821419 | ||
| Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device | Q36877212 | ||
| Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles | Q36970889 | ||
| Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety | Q37240616 | ||
| Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug. | Q37319709 | ||
| The therapeutic potential of phosphatase inhibitors | Q37467605 | ||
| Lipid-coated Cisplatin nanoparticles induce neighboring effect and exhibit enhanced anticancer efficacy | Q37531501 | ||
| Synthetic methods for the preparation of platinum anticancer complexes | Q37722632 | ||
| The effects of polymeric nanostructure shape on drug delivery | Q37903444 | ||
| A Potent Glucose-Platinum Conjugate Exploits Glucose Transporters and Preferentially Accumulates in Cancer Cells. | Q38411327 | ||
| Trigger responsive polymeric nanocarriers for cancer therapy | Q38556755 | ||
| Polymeric biomaterials for the delivery of platinum-based anticancer drugs | Q38556758 | ||
| Bio-inspired cisplatin nanocarriers for osteosarcoma treatment | Q38763844 | ||
| Enzyme-Instructed Self-Assembly of Small D-Peptides as a Multiple-Step Process for Selectively Killing Cancer Cells. | Q38787120 | ||
| Polymer nanoparticle delivery of dichloroacetate and DACH-Pt to enhance antitumor efficacy and lower systemic toxicity | Q38799444 | ||
| Unique Use of Alkylation for Chemo-Redox Activity by a Pt(IV) Prodrug | Q38799693 | ||
| Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy. | Q38841311 | ||
| Overcoming tumor resistance to cisplatin through micelle-mediated combination chemotherapy | Q38848959 | ||
| Controlling cancer cell fate using localized biocatalytic self-assembly of an aromatic carbohydrate amphiphile | Q38925570 | ||
| ATP-triggered anticancer drug delivery | Q39016466 | ||
| Methoxypoly(ethylene glycol)-block-poly(L-glutamic acid)-loaded cisplatin and a combination with iRGD for the treatment of non-small-cell lung cancers | Q39258510 | ||
| Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin | Q39371480 | ||
| Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. | Q39381365 | ||
| Platinum (IV)-coordinate polymers as intracellular reduction-responsive backbone-type conjugates for cancer drug delivery. | Q39480090 | ||
| Overcoming tumor resistance to cisplatin by cationic lipid-assisted prodrug nanoparticles. | Q39843392 | ||
| Molecular modelling studies, synthesis and biological activity of a series of novel bisnaphthalimides and their development as new DNA topoisomerase II inhibitors | Q39908467 | ||
| Nanoscale coordination polymers for platinum-based anticancer drug delivery | Q39953052 | ||
| Smart and hyper-fast responsive polyprodrug nanoplatform for targeted cancer therapy | Q40345936 | ||
| Synthesis, characterization, and cytotoxicity of a series of estrogen-tethered platinum(IV) complexes | Q40560059 | ||
| Curcumin polymers as anticancer conjugates | Q42998427 | ||
| PEG-sheddable polyplex micelles as smart gene carriers based on MMP-cleavable peptide-linked block copolymers | Q44849024 | ||
| Platinum (IV) pro-drug conjugated NaYF4 :Yb(3+) /Er(3+) nanoparticles for targeted drug delivery and up-conversion cell imaging. | Q45064469 | ||
| Biotransformation on polymer-peptide conjugates: a versatile tool to trigger microstructure formation. | Q45934485 | ||
| Dimeric drug polymeric nanoparticles with exceptionally high drug loading and quantitative loading efficiency | Q46121483 | ||
| Nanoscale Coordination Polymers Codeliver Chemotherapeutics and siRNAs to Eradicate Tumors of Cisplatin-Resistant Ovarian Cancer | Q46940314 | ||
| Smart Superstructures with Ultrahigh pH-Sensitivity for Targeting Acidic Tumor Microenvironment: Instantaneous Size Switching and Improved Tumor Penetration | Q47300042 | ||
| Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size | Q47348224 | ||
| The prodrug platin-A: simultaneous release of cisplatin and aspirin. | Q51757111 | ||
| Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy. | Q53356199 | ||
| Targeted theranostic platinum(IV) prodrug with a built-in aggregation-induced emission light-up apoptosis sensor for noninvasive early evaluation of its therapeutic responses in situ. | Q53637592 | ||
| Theory of Stationary Electrode Polarography. Single Scan and Cyclic Methods Applied to Reversible, Irreversible, and Kinetic Systems | Q55953467 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 1558-1566 | |
| P577 | publication date | 2017-02-09 | |
| P1433 | published in | Biomaterials Science | Q27724497 |
| P1476 | title | Phosphatase-triggered cell-selective release of a Pt(iv)-backboned prodrug-like polymer for an improved therapeutic index | |
| P478 | volume | 5 |
| Q64259843 | Machine Learning Approach for Determining the Formation of β-Lactam Antibiotic Complexes with Cyclodextrins Using Multispectral Analysis | cites work | P2860 |
Search more.